by Brandon Tudor | Jun 30, 2025 | Uncategorized
A recent study entitled “MetALD, ALD Linked to Higher Liver Risks and Mortality in Steatotic Liver Disease” indicates the following– 🧬 “MetALD” (Metabolic and Alcohol-associated Liver Disease) Defined as steatotic liver disease with both metabolic...
by Brandon Tudor | Jun 26, 2025 | Uncategorized
Here’s a summary of the WorldHealth.net article “Liver Health and MASH: What You Need to Know About the Silent Epidemic”: 🩺 What is MASH? MASH (Metabolic Dysfunction-Associated Steatohepatitis), formerly NASH, is an advanced form of fatty liver disease characterized...
by Brandon Tudor | Jun 24, 2025 | Uncategorized
Wait times to see a provider in America are long … and even more so in Liver Disease (Hepatology). Give this June-2025 article Wait Times to See Physicians Continue to Climb a read (summarized below).LiverRight gets adult patients for diagnosis or care in...
by Brandon Tudor | Jun 19, 2025 | Uncategorized
From JAMA Internal Medicine, June 16, 2025: Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease. Objective:To compare the risk of adverse liver outcomes, major cardiovascular events, and all-cause mortality among people with...
by Brandon Tudor | Jun 16, 2025 | Uncategorized
🏆 States on‑track to eliminate HCV by 2030 A 2020–17 model projected only three states—Connecticut, South Carolina, and Washington—are on pace to meet all WHO HCV elimination targets (diagnosis, treatment, incidence, mortality) by 2030 💊 Medicaid innovations &...
